Air taxi company Beta completes first test flights in U.S. government program

Beta Technologies, an electric vertical takeoff and landing (eVTOL) aircraft developer, announced on Friday the completion of its first test flights within the U.S. government's extensive eVTOL pilot program, designed to advance the concept of flying cars.

The flights, conducted in partnership with United Therapeutics, focused on transporting cultured organs between Maryland and Virginia. The total flight distance covered approximately 275 nautical miles. Beta CEO Kyle Clark stated in a release that these successful missions "set the stage for routine medical applications through electric flight at a much lower cost nationwide."

The industry has long envisioned flying cars as a solution to traffic congestion, with potential applications in medical transport, cargo, and defense. Beta is among several eVTOL manufacturers vying for Federal Aviation Administration (FAA) certification to commence commercial passenger flights. However, certification timelines have been extended due to the complexities involved in the approval process.

The program, spearheaded by the Department of Transportation and the FAA, is part of a broader initiative to foster the development of aerial mobility. Beta has emerged as the most active participant, involved in seven out of eight launched testing projects. The company's eVTOL aircraft is projected to achieve certification in 2028, with its conventional takeoff and landing aircraft targeting certification in 2027.

Beta's advancements occur amid a challenging market for eVTOL stocks, with several competitors, including Joby Aviation and Archer Aviation, experiencing significant share price declines. The sector has also faced legal disputes that have impacted the progression towards commercial operations.